Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia - The pathogenic role of IgG

By Untch B.   Ahmad S.   Jeske W.P.   Messmore H.L.   Hoppensteadt D.A.   Walenga J.M.   Lietz H.   Fareed J.  

Thrombosis Research, Vol. 105, Iss. 2, 2002-01 ,pp. : 117-123

Elsevier

Access to resources Recommend Favorite

Transitioning from Argatroban to Warfarin in Heparin-Induced Thrombocytopenia: An Analysis of Outcomes in Patients with Elevated International Normalized Ratio (INR)

By Bartholomew John   Hursting Marcie  

Journal of Thrombosis and Thrombolysis, Vol. 19, Iss. 3, 2005-06 ,pp. : 183-188

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Patients with a History of Heparin-Induced Thrombocytopenia and Anti-Lepirudin Antibodies with Argatroban

By Job Harenberg   Ingrid Jörg   Tivadar Fenyvesi   Lukas Piazolo  

Journal of Thrombosis and Thrombolysis, Vol. 19, Iss. 1, 2005-02 ,pp. : 65-69

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Patients with a History of Heparin-Induced Thrombocytopenia and Anti-Lepirudin Antibodies with Argatroban

By Job Harenberg   Ingrid Jörg   Tivadar Fenyvesi   Lukas Piazolo  

Journal of Thrombosis and Thrombolysis, Vol. 20, Iss. 2, 2005-10 ,pp. : 137-137

Springer Publishing Company

Access to resources Recommend Favorite

Bivalirudin: Alternative Anticoagulation During Cardiopulmonary Bypass in Patients with Heparin-Induced Thrombocytopenia

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 20-24

Bentham Science Publishers

Access to resources Recommend Favorite